A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer

被引：0
|
作者：
Saito, K. O. [1 ]
Nakai, Y. [1 ]
Isayama, H. [2 ]
Ishigaki, K. [1 ]
Saito, T. [1 ]
Takahara, N. [1 ]
Mizuno, S. [1 ]
Kogure, H. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan
[2] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
737P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II multicentric trial of combined chemotherapy with gemcitabine plus S-1 in patients with advanced pancreatic cancer
    Ohkawa, S.
    Amano, A.
    Ueno, M.
    Miyakawa, K.
    Sugimori, K.
    Tanaka, K.
    Kida, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Multicenter Phase II Study of Gemcitabine and S-1 Combination Therapy (GS Therapy) in Patients With Metastatic Pancreatic Cancer
    Ueno, Hideki
    Okusaka, Takuji
    Furuse, Junji
    Yamao, Kenji
    Funakoshi, Akihiro
    Boku, Narikazu
    Ohkawa, Shinichi
    Yokosuka, Osamu
    Tanaka, Katsuaki
    Moriyasu, Fuminori
    Nakamori, Shoji
    Sato, Tosiya
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 953 - 958
  • [23] A multicenter phase II study of gemcitabine and S-1 combination therapy (GS therapy) in patients with metastatic pancreatic cancer
    Ueno, H.
    Okusaka, T.
    Furuse, J.
    Yamao, K.
    Funakoshi, A.
    Boku, N.
    Ohkawa, S.
    Makimoto, A.
    Sato, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer
    Yamauchi, Junichi
    Kanai, Masashi
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Yazumi, Shujiro
    Kami, Kazuhiro
    Kawaguchi, Yoshiya
    Yasuda, Hiroyasu
    Kitano, Toshiyuki
    Misawa, Akiko
    Ishiguro, Hiroshi
    Yoshikawa, Kiyotsugu
    Yanagihara, Kazuhiro
    Fukushima, Masanori
    Doi, Ryuichiro
    Chiba, Tsutomu
    [J]. PANCREAS, 2008, 36 (03) : 327 - 328
  • [25] Combination therapy of gemcitabine and S-1 in patients with metastatic pancreatic cancer
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Sudou, Kentarou
    Hara, Tarou
    Denda, Tadamichi
    Ishihara, Takeshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A89 - A89
  • [26] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Kentaro Sudo
    Taketo Yamaguchi
    Kazuyoshi Nakamura
    Tadamichi Denda
    Taro Hara
    Takeshi Ishihara
    Osamu Yokosuka
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 249 - 254
  • [27] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Sudo, Kentaro
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Denda, Tadamichi
    Hara, Taro
    Ishihara, Takeshi
    Yokosuka, Osamu
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 249 - 254
  • [28] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [29] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Do-Youn Oh
    Yongjun Cha
    In-Sil Choi
    So-Young Yoon
    In Keun Choi
    Jee Hyun Kim
    Sang Cheul Oh
    Chang Duck Kim
    Jae Sun Kim
    Yung-Jue Bang
    Yeul Hong Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 65 : 527 - 536
  • [30] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Oh, Do-Youn
    Cha, Yongjun
    Choi, In-Sil
    Yoon, So-Young
    Choi, In Keun
    Kim, Jee Hyun
    Oh, Sang Cheul
    Kim, Chang Duck
    Kim, Jae Sun
    Bang, Yung-Jue
    Kim, Yeul Hong
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 527 - 536
12345